The AICE program supports Alberta health technology ventures to grow and generate the evidence needed along their journey to achieve validation, market access, and start scaling. The objectives are to mitigate the risks faced by innovative Alberta health technology SMEs that require preclinical and clinical evidence to get to market by providing non-dilutive funding and access to advice and partners along the way.
AICE offers two funding streams, Validate, and Market Access, based-upon the proposed project activities and the stage of readiness of the technology, the product-market fit, the business, and regulatory compliance.